Roche (OTCMKTS:RHHBY) Hits New 1-Year High – Here’s What Happened

Roche Holding AG (OTCMKTS:RHHBY) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $56.12 and last traded at $56.12, with a volume of 166379 shares. The stock had previously closed at $55.23.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Barclays raised Roche from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, January 6th. Deutsche Bank Aktiengesellschaft raised Roche from a “sell” rating to a “hold” rating in a report on Tuesday, November 11th. HSBC reissued a “buy” rating and issued a $57.00 price objective on shares of Roche in a research note on Wednesday, December 10th. The Goldman Sachs Group upgraded shares of Roche from a “sell” rating to a “hold” rating in a research note on Thursday, January 15th. Finally, Hsbc Global Res raised shares of Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 2nd. Three research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Roche presently has a consensus rating of “Moderate Buy” and an average target price of $57.00.

Roche Stock Performance

The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.02 and a current ratio of 1.29. The firm’s 50-day simple moving average is $50.92 and its 200 day simple moving average is $44.87.

Institutional Investors Weigh In On Roche

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Boston Common Asset Management LLC grew its holdings in shares of Roche by 1.9% in the 3rd quarter. Boston Common Asset Management LLC now owns 368,553 shares of the company’s stock worth $15,049,000 after acquiring an additional 6,720 shares during the period. OLD National Bancorp IN boosted its position in Roche by 2.9% during the second quarter. OLD National Bancorp IN now owns 261,317 shares of the company’s stock worth $10,604,000 after purchasing an additional 7,326 shares in the last quarter. Altrius Capital Management Inc grew its holdings in Roche by 4.0% in the third quarter. Altrius Capital Management Inc now owns 198,278 shares of the company’s stock valued at $8,290,000 after purchasing an additional 7,659 shares during the last quarter. Bard Financial Services Inc. increased its position in shares of Roche by 1.3% in the third quarter. Bard Financial Services Inc. now owns 138,650 shares of the company’s stock valued at $5,797,000 after buying an additional 1,800 shares in the last quarter. Finally, Rhumbline Advisers raised its stake in shares of Roche by 1.1% during the 2nd quarter. Rhumbline Advisers now owns 108,480 shares of the company’s stock worth $4,422,000 after buying an additional 1,228 shares during the last quarter.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.